LTIP862A - Method for preparing amino acid derivatives and pharmaceuthical compositions thereof - Google Patents

Method for preparing amino acid derivatives and pharmaceuthical compositions thereof

Info

Publication number
LTIP862A
LTIP862A LTIP862A LTIP862A LTIP862A LT IP862 A LTIP862 A LT IP862A LT IP862 A LTIP862 A LT IP862A LT IP862 A LTIP862 A LT IP862A LT IP862 A LTIP862 A LT IP862A
Authority
LT
Lithuania
Prior art keywords
pharmaceuthical
compositions
amino acid
acid derivatives
preparing amino
Prior art date
Application number
LTIP862A
Inventor
Joseph Armstrong Martin
Sally Redshaw
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of LTIP862A publication Critical patent/LTIP862A/en
Publication of LT3682B publication Critical patent/LT3682B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Cleaning Or Clearing Of The Surface Of Open Water (AREA)
  • Hydrogenated Pyridines (AREA)
  • Measurement Of Force In General (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Compounds of the general formula <CHEM> wherein R represents benzyloxycarbonyl or 2-quinolylcarbonyl, and their pharmaceutically acceptable acid addition salts inhibit proteases of viral origin and can be used as medicaments for the treatment or prophylaxis of viral infections.
LTIP862A 1989-12-11 1993-08-16 Method for preparing amino acid derivatives and pharmaceuthical compositions thereof LT3682B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898927913A GB8927913D0 (en) 1989-12-11 1989-12-11 Amino acid derivatives
SG120493A SG120493G (en) 1989-12-11 1993-11-02 N-tert-Butyl-decahydro-2(3-amino-2-hydroxy-4-phenyl-butyl) isoquinoline-3-carboxamide and asparaginyl derivatives thereof

Publications (2)

Publication Number Publication Date
LTIP862A true LTIP862A (en) 1995-03-27
LT3682B LT3682B (en) 1996-01-25

Family

ID=26296345

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP862A LT3682B (en) 1989-12-11 1993-08-16 Method for preparing amino acid derivatives and pharmaceuthical compositions thereof

Country Status (48)

Country Link
US (1) US5196438A (en)
EP (1) EP0432695B1 (en)
JP (1) JP2807093B2 (en)
KR (1) KR970005912B1 (en)
CN (2) CN1034805C (en)
AT (1) ATE122661T1 (en)
AU (1) AU634319B2 (en)
BG (1) BG51452A3 (en)
BR (1) BR9006264A (en)
CA (1) CA2030433C (en)
CU (1) CU22305A3 (en)
CZ (1) CZ280558B6 (en)
DE (2) DE69019481T2 (en)
DK (1) DK0432695T3 (en)
DZ (1) DZ1467A1 (en)
EG (1) EG19722A (en)
ES (1) ES2072959T3 (en)
FI (2) FI973895A0 (en)
GB (2) GB8927913D0 (en)
GR (1) GR3017114T3 (en)
HK (1) HK129093A (en)
HR (1) HRP930341B1 (en)
HU (2) HU207298B (en)
ID (1) ID1018B (en)
IE (1) IE67523B1 (en)
IL (1) IL96550A (en)
IN (1) IN172553B (en)
IS (1) IS1803B (en)
LT (1) LT3682B (en)
LU (1) LU90014I2 (en)
LV (1) LV5738B4 (en)
MA (1) MA22014A1 (en)
MC (1) MC2195A1 (en)
MT (1) MTP1075B (en)
MW (1) MW8890A1 (en)
MX (1) MX173630B (en)
NL (1) NL970013I2 (en)
NO (1) NO176566C (en)
OA (1) OA09334A (en)
PL (1) PL165225B1 (en)
PT (1) PT96145B (en)
RO (1) RO107942B1 (en)
RU (1) RU2071470C1 (en)
SG (1) SG120493G (en)
SI (1) SI9012315B (en)
SK (1) SK576590A3 (en)
ZA (1) ZA909743B (en)
ZW (1) ZW17490A1 (en)

Families Citing this family (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878728B1 (en) 1999-06-11 2005-04-12 Vertex Pharmaceutical Incorporated Inhibitors of aspartyl protease
US20040122000A1 (en) * 1981-01-07 2004-06-24 Vertex Pharmaceuticals Incorporated. Inhibitors of aspartyl protease
US5614533A (en) * 1987-03-13 1997-03-25 Bio-Mega/Boehringer Ingelheim Research, Inc. Substituted pipecolinic acid derivatives as HIV protease inhibitors
USH1649H (en) 1987-07-31 1997-05-06 Barrish; Joel C. HIV protease inhibitor combinations
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
GB8927915D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Novel alcohols
US5430041A (en) * 1991-05-10 1995-07-04 Hoffmann-La Roche Inc. Amino acid derivatives having antiviral activity
US5508407A (en) * 1991-07-10 1996-04-16 Eli Lilly And Company Retroviral protease inhibitors
CN1071930A (en) * 1991-07-10 1993-05-12 伊莱利利公司 Inhibitors of human immunodeficiency virus protease for the treatment of AIDS
WO1993008184A1 (en) * 1991-10-23 1993-04-29 Merck & Co., Inc. Hiv protease inhibitors
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
SG52731A1 (en) * 1991-11-08 1998-09-28 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
CA2130754C (en) 1992-03-11 2005-02-08 Damian W. Grobelny Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
DE69300043T2 (en) * 1992-03-13 1995-05-24 Bio Mega Boehringer Ingelheim Substituted pipecoline acid derivatives as HIV protease inhibitors.
ATE199545T1 (en) * 1992-05-21 2001-03-15 Monsanto Co INHIBITORS OF RETROVIRAL PROTEASES
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
PT810209E (en) 1992-08-25 2002-09-30 Searle & Co HYDROXYETHYLAMINO-SULFONAMIDES OF ALPHA- AND BETA-AMINOACIDOS UTEIS AS INHIBITORS OF RETROVIRAL PROTEASE
IS2334B (en) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl protease inhibitor of a new class of sulfonamides
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
US5783701A (en) * 1992-09-08 1998-07-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
TW372972B (en) * 1992-10-23 1999-11-01 Novartis Ag Antiretroviral acyl compounds
US5380849A (en) * 1992-11-09 1995-01-10 Merck & Co., Inc. Process for optically pure decahydroisoqiunolines
US5430150A (en) * 1992-12-16 1995-07-04 American Cyanamid Company Retroviral protease inhibitors
US5491166A (en) * 1992-12-22 1996-02-13 Eli Lilly And Company Inhibitors of HIV protease useful for the treatment of AIDS
MX9308025A (en) * 1992-12-22 1994-08-31 Lilly Co Eli HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITING COMPOUNDS, PROCEDURE FOR SUPREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
US5846993A (en) * 1992-12-22 1998-12-08 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5733906A (en) * 1993-10-12 1998-03-31 Eli Lilly And Company Inhibitors of HIV Protease useful for the treatment of Aids
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5434265A (en) * 1992-12-22 1995-07-18 Eli Lilly And Company Inhibitors of HIV protease
MX9308016A (en) * 1992-12-22 1994-08-31 Lilly Co Eli HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITING COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
AU6161794A (en) * 1993-01-17 1994-08-15 Schering Corporation Peptides having anti-hiv activity
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
US5455353A (en) * 1993-03-24 1995-10-03 Hoffmann-La Roche Inc. 4-(benzyl-2-oxo-oxazolidin-5 ylmethyl)N tertbutyl-decahydroisoquinoline-3-carboxamides
EP0738724B1 (en) * 1993-07-15 1998-11-04 F. Hoffmann-La Roche Ag Process for the preparation of an N-terbutylamide derivative
CA2182090A1 (en) * 1994-02-02 1995-08-10 William Joseph Hornback Hiv protease inhibitors and intermediates
EP0749421B1 (en) * 1994-03-07 1999-09-15 Vertex Pharmaceuticals Incorporated Sulphonamide derivatives as aspartyl protease inhibitors
US5527829A (en) * 1994-05-23 1996-06-18 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5470979A (en) * 1994-07-01 1995-11-28 American Cyanamid Company Asymmetric synthesis of bicyclic amino acid esters
US5523463A (en) * 1994-09-23 1996-06-04 Hoffmann-La Roche Inc. Method of producing halogenated and alpha-aminoalchohols
US5591885A (en) * 1994-09-23 1997-01-07 Hoffman-La Roche Inc. Process for the preparation of halogenated α-aminoketone compounds
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
HU223899B1 (en) * 1995-06-06 2005-03-29 F.Hoffmann-La Roche Ag. Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
US6004957A (en) * 1995-06-07 1999-12-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
AU759386B2 (en) * 1995-06-29 2003-04-10 Abbvie Inc. Use of Ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating AIDS
CA2235394A1 (en) 1995-11-13 1997-05-22 Gerard Voerman Anti-viral isolates obtainable from leeches
US5914332A (en) 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
US5883252A (en) * 1996-01-26 1999-03-16 Vertex Pharmaceuticals Incorporated Aspartyl protease inhibitors
US5587481A (en) * 1996-02-20 1996-12-24 The Monsanto Company Preparation of (S)-decahydroisoquinoline-3-carboxylic acid t-butylamide
US5914404A (en) * 1996-08-09 1999-06-22 Hoffmann-La Roche Inc. Process for the preparation of quinargine
EP0823424A1 (en) * 1996-08-09 1998-02-11 F. Hoffmann-La Roche Ag Process for the preparation of quinargine
US5705647A (en) * 1996-09-05 1998-01-06 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
US5925759A (en) 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US5962725A (en) 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US6232333B1 (en) 1996-11-21 2001-05-15 Abbott Laboratories Pharmaceutical composition
DE59709770D1 (en) 1996-12-11 2003-05-15 Hoffmann La Roche Process for the preparation of mixed anhydrides
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US6084107A (en) * 1997-09-05 2000-07-04 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
US6143742A (en) * 1997-12-11 2000-11-07 Fuisz Technologies Ltd Treatment for necrotizing infections
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
FR2779653B1 (en) * 1998-06-11 2002-12-20 Inst Nat Sante Rech Med USE OF PROTEASOME MODULATING COMPOUNDS IN THERAPY
DK1086076T3 (en) * 1998-06-19 2005-03-29 Vertex Pharma Sulfonamide inhibitors of aspartyl protease
BR9914785A (en) * 1998-10-21 2001-07-03 Fujisawa Pharmaceutical Co Formavitreous 8- [3- [n - [(e) -3- (6-acetamidopyridin-3-yl) acryloylglycyl] -n-methylamino] -2,6-dichlorobenzyloxy) -2-methylquinoline, process for its preparation, pharmaceutical composition comprising the same, prevention agent, its methods and use
KR100277723B1 (en) 1998-12-14 2001-01-15 남창우 Continuous manufacturing process of optically pure decahydroisoquinolinecarboxamide
US7115584B2 (en) * 1999-01-22 2006-10-03 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7635690B2 (en) * 1999-01-22 2009-12-22 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
DE60042092D1 (en) * 1999-06-04 2009-06-04 Abbott Lab Pharmaceutical preparations containing at least one HIV Preoteaseinhibitor
EP1202626A4 (en) * 1999-07-20 2002-10-30 Merck & Co Inc ALPHA-HYDROXY-GAMMA DERIVATIVES - [[(CARBOCYCLICS-OR HETEROCYCLICS-SUBSTITUTED) AMINO] CARBONYL] ALCANAMIDE AND USES THEREOF
US6589962B1 (en) 1999-07-20 2003-07-08 Merck & Co., Inc. Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof
JP2003514910A (en) 1999-11-24 2003-04-22 メルク エンド カムパニー インコーポレーテッド Gamma-hydroxy-2- (fluoroalkylaminocarbonyl) -1-piperazinepentanamides as HIV protease inhibitors
IT1313682B1 (en) * 1999-11-25 2002-09-09 Archimica Spa PROCEDURE FOR THE PREPARATION OF (S) -N-TERBUTYL-1,2,3,4-TETRAIDROISOCHINOLIN-3-CARBOXYAMIDE.
EP1248600B1 (en) 2000-01-19 2008-05-14 Abbott Laboratories Improved hiv protease inhibitors pharmaceutical formulations
AU2001259817A1 (en) 2000-05-04 2001-11-12 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health Methods of and compounds for inhibiting calpains
IT1318986B1 (en) * 2000-10-09 2003-09-19 Archimica S P A Ora Clariant L PROCEDURE FOR THE PREPARATION OF (S) -N-TERBUTYL-1,2,3,4-TETRAIDROISOCHINOLIN-3-CARBOXYAMIDE.
GB0028483D0 (en) 2000-11-22 2001-01-10 Hoffmann La Roche Hydroxyethylamine HIV protease inhibitors
US20030191121A1 (en) * 2001-08-09 2003-10-09 Miller Ross A. Piperazine carboxamide intermediates of HIV protease inhibitors and processes for their preparation
EP1463807A4 (en) 2001-12-19 2006-04-12 Bristol Myers Squibb Co Pichia pastoris formate dehydrogenase and uses therefor
US20040067216A1 (en) * 2002-02-22 2004-04-08 Karki Shyam B. Hiv protease inhibitors supported on cation exchange resins for oral administration
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US7157489B2 (en) * 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
US7115652B2 (en) * 2002-06-17 2006-10-03 Sunesis Pharmaceuticals, Inc. Aspartyl protease inhibitors
US7132568B2 (en) * 2002-06-17 2006-11-07 Sunesis Pharmaceuticals, Inc. Aspartyl protease inhibitors
KR20070087194A (en) * 2003-07-11 2007-08-27 에프. 호프만-라 로슈 아게 Saquinavir mesylate oral dosage form
EP1604662A1 (en) * 2004-06-08 2005-12-14 Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft 1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus
DE602005027466D1 (en) 2004-07-27 2011-05-26 Gilead Sciences Inc NUCLEOSIDE PHOSPHONATE CONJUGATES AS ANTI HIV MEDIUM
WO2006134612A1 (en) * 2005-06-16 2006-12-21 Hetero Drugs Limited A process for the preparation of saquinavir using novel intermediate
US8598364B2 (en) 2007-03-12 2013-12-03 Nektar Therapeutics Oligomer-protease inhibitor conjugates
WO2009006203A1 (en) * 2007-06-29 2009-01-08 Gilead Sciences, Inc. Therapeutic compositions and the use thereof
TW200914011A (en) * 2007-06-29 2009-04-01 Gilead Sciences Inc Therapeutic compositions and methods
JP2010540517A (en) * 2007-09-25 2010-12-24 メルク・シャープ・エンド・ドーム・コーポレイション HIV protease inhibitor
WO2009114151A1 (en) * 2008-03-12 2009-09-17 Nektar Therapeutics Oligomer-amino acid and olgomer-atazanavir conjugates
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
DK2364314T3 (en) 2008-12-09 2014-05-12 Gilead Sciences Inc Modulators of toll-like receptors
AR074897A1 (en) * 2008-12-23 2011-02-23 Pharmasset Inc NUCLEOSID PHOSPHORAMIDATES
WO2010075554A1 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Synthesis of purine nucleosides
WO2010075517A2 (en) * 2008-12-23 2010-07-01 Pharmasset, Inc. Nucleoside analogs
EP2435037B1 (en) 2009-05-27 2014-11-12 Merck Sharp & Dohme Corp. Hiv protease inhibitors
JP2012530069A (en) 2009-06-12 2012-11-29 ネクター セラピューティックス Covalent conjugate comprising a protease inhibitor, a water-soluble non-peptide oligomer and a lipophilic moiety
DE102010004957A1 (en) 2010-01-14 2011-07-21 Universitätsklinikum Jena, 07743 Biologically active molecules for influencing virus, bacterial, parasite-infected cells and / or tumor cells and methods for their use
US20110223131A1 (en) 2010-02-24 2011-09-15 Gilead Sciences, Inc. Antiviral compounds
RS54368B1 (en) 2010-03-31 2016-04-28 Gilead Pharmasset Llc CRYSTAL (S) -ISOPROPYL 2 - ((((S) - ((((2R, 3R, 4R, 5R) -5- (2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1- (2H) -IL) - 4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-IL) METOXY) (PHENOXY) PHOSPHORYL) AMINO) PROPANOATE
WO2012055031A1 (en) 2010-10-28 2012-05-03 Merck Canada Inc. Hiv protease inhibitors
EP2392926A1 (en) 2011-02-09 2011-12-07 Roche Diagnostics GmbH Urinary biomarkers in HIV infected subjects
US9133157B2 (en) 2011-10-26 2015-09-15 Merck Canada Inc. HIV protease inhibitors
WO2013105118A1 (en) 2012-01-10 2013-07-18 Council Of Scientific & Industrial Research A process for synthesis of syn azido epoxide and its use as intermediate the synthesis of amprenavir & saquinavir
AU2013315833A1 (en) 2012-09-11 2015-03-05 Merck Canada Inc. HIV protease inhibitors
CA2889903C (en) 2012-10-29 2021-03-09 Manjinder Singh Phull Antiviral phosphonate analogues and process for preparation thereof
WO2015013835A1 (en) 2013-07-31 2015-02-05 Merck Sharp & Dohme Corp. Piperazine derivatives as hiv protease inhibitors
WO2015095276A1 (en) 2013-12-19 2015-06-25 Merck Sharp & Dohme Corp. Hiv protease inhibitors
EP3083609B1 (en) 2013-12-19 2018-08-15 Merck Sharp & Dohme Corp. Hiv protease inhibitors
EP3113780B1 (en) 2014-03-06 2019-08-14 Merck Sharp & Dohme Corp. Hiv protease inhibitors
US10138255B2 (en) 2014-03-10 2018-11-27 Merck Sharp & Dohme Corp. Piperazine derivatives as HIV protease inhibitors
WO2016001907A1 (en) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
TWI733652B (en) 2014-07-11 2021-07-21 美商基利科學股份有限公司 Modulators of toll-like receptors for the treatment of hiv
US9738664B2 (en) 2014-10-29 2017-08-22 Wisconsin Alumni Research Foundation Boronic acid inhibitors of HIV protease
WO2017048727A1 (en) 2015-09-15 2017-03-23 Gilead Sciences, Inc. Modulators of toll-like recptors for the treatment of hiv
WO2021209563A1 (en) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB933968A (en) * 1960-10-26 1963-08-14 May & Baker Ltd New phthalimide derivatives
US4123543A (en) * 1971-09-16 1978-10-31 Ab Kabi Derivatives of substituted indoline lactans with effect on the central nervous system
US3901897A (en) * 1972-10-05 1975-08-26 Squibb & Sons Inc 1,2,3,4,4a,5,6,7-octahydro-7-aryl-isoquinolines and derivatives thereof
US4329473A (en) * 1979-06-01 1982-05-11 Almquist Ronald G Oxoalkanoic acid derivatives as inhibitors of angiotensin converting enzyme
SE421551B (en) * 1980-03-26 1982-01-04 Sandvik Ab DRILLING TOOL FOR ROTATION AND / OR DRILLING
US4470973A (en) * 1982-07-19 1984-09-11 E. R. Squibb & Sons, Inc. Substituted peptide compounds
US4812442A (en) * 1984-05-29 1989-03-14 Merck & Co., Inc. Tripeptide renin inhibitors
FR2575753B1 (en) * 1985-01-07 1987-02-20 Adir NOVEL PEPTIDE DERIVATIVES WITH NITROGEN POLYCYCLIC STRUCTURE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
AT383762B (en) * 1985-12-23 1987-08-25 Plansee Metallwerk METHOD FOR PRODUCING MULTI-COMPONENT, CONGRUENTLY MELTING SOLDER MATERIALS
CA1286989C (en) * 1985-12-26 1991-07-30 A. Arthur Gottlieb Immunoamplifiers and related compositions
WO1988000939A1 (en) * 1986-07-25 1988-02-11 Banyu Pharmaceutical Co., Ltd. Optically active amino alcohol derivatives and process for their preparation
DE3789347D1 (en) * 1986-10-14 1994-04-21 Banyu Pharma Co Ltd 5-Substituted amino-4-hydroxy-pentanoic acid derivatives and their use.
US4863905A (en) * 1987-02-04 1989-09-05 Warner-Lambert Company Renin inhibitors II
FR2610934B1 (en) * 1987-02-13 1989-05-05 Adir NOVEL PEPTIDE DERIVATIVES WITH NITROGEN POLYCYCLIC STRUCTURE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
DE3717631A1 (en) * 1987-05-26 1988-12-15 Merck Patent Gmbh AMINO ACID DERIVATIVES
DE3733296A1 (en) * 1987-10-02 1989-04-20 Merck Patent Gmbh AMINOSAEUREDERIVATE
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
DE4033062A1 (en) * 1990-10-18 1992-04-23 Merck Patent Gmbh AMINOSAEUREDERIVATE
GB8927915D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Novel alcohols

Also Published As

Publication number Publication date
MC2195A1 (en) 1992-10-05
IE904453A1 (en) 1991-06-19
DE19675051I2 (en) 2001-04-12
NO905322L (en) 1991-06-12
PT96145A (en) 1991-09-30
FI905983L (en) 1991-06-12
HK129093A (en) 1993-12-03
ID1018B (en) 1996-10-18
IL96550A (en) 1995-03-15
FI973895L (en) 1997-10-06
PL165225B1 (en) 1994-11-30
FI905983A0 (en) 1990-12-04
HRP930341A2 (en) 1994-10-31
DK0432695T3 (en) 1995-09-11
AU6787690A (en) 1991-06-13
CN1138983A (en) 1997-01-01
MA22014A1 (en) 1991-07-01
RU2071470C1 (en) 1997-01-10
GB2239016A (en) 1991-06-19
LV5738B4 (en) 1996-12-20
CU22305A3 (en) 1995-01-31
IE67523B1 (en) 1996-04-03
IS1803B (en) 2002-02-26
HU207298B (en) 1993-03-29
NL970013I1 (en) 1997-05-01
SK280249B6 (en) 1999-10-08
ZA909743B (en) 1991-08-28
GB9026776D0 (en) 1991-01-30
BR9006264A (en) 1991-09-24
IN172553B (en) 1993-09-25
JP2807093B2 (en) 1998-09-30
IS3651A7 (en) 1991-06-12
EG19722A (en) 1996-01-31
SG120493G (en) 1994-01-21
NL970013I2 (en) 1997-09-01
EP0432695A2 (en) 1991-06-19
OA09334A (en) 1992-09-15
PL288201A1 (en) 1991-09-09
FI973895A7 (en) 1997-10-06
IL96550A0 (en) 1991-09-16
ATE122661T1 (en) 1995-06-15
LT3682B (en) 1996-01-25
GR3017114T3 (en) 1995-11-30
MW8890A1 (en) 1991-03-13
MTP1075B (en) 1991-07-31
BG51452A3 (en) 1993-05-14
EP0432695B1 (en) 1995-05-17
DZ1467A1 (en) 2004-09-13
RO107942B1 (en) 1994-01-31
DE69019481D1 (en) 1995-06-22
ZW17490A1 (en) 1992-06-17
HU211342A9 (en) 1995-11-28
EP0432695A3 (en) 1991-12-18
MX23619A (en) 1993-10-01
CA2030433C (en) 1997-10-21
DE69019481T2 (en) 1995-11-09
US5196438A (en) 1993-03-23
CN1066329C (en) 2001-05-30
HU908076D0 (en) 1991-06-28
SI9012315B (en) 1998-06-30
NO176566B (en) 1995-01-16
LV5738A4 (en) 1996-08-20
PT96145B (en) 1998-04-30
LU90014I2 (en) 1997-01-31
SK576590A3 (en) 1999-10-08
NO905322D0 (en) 1990-12-10
NO176566C (en) 1995-04-26
GB2239016B (en) 1993-08-04
CN1034805C (en) 1997-05-07
HUT56073A (en) 1991-07-29
AU634319B2 (en) 1993-02-18
ES2072959T3 (en) 1995-08-01
SI9012315A (en) 1997-10-31
HRP930341B1 (en) 1998-12-31
CZ576590A3 (en) 1995-11-15
KR970005912B1 (en) 1997-04-22
CA2030433A1 (en) 1991-06-12
KR910011894A (en) 1991-08-07
FI973895A0 (en) 1997-10-06
FI100883B (en) 1998-03-13
JPH03255076A (en) 1991-11-13
CZ280558B6 (en) 1996-02-14
CN1052482A (en) 1991-06-26
MX173630B (en) 1994-03-18
GB8927913D0 (en) 1990-02-14

Similar Documents

Publication Publication Date Title
LTIP862A (en) Method for preparing amino acid derivatives and pharmaceuthical compositions thereof
PL310895A1 (en) Hiv protease inhibitors in aids treating pharmaceutic compositions
HUT51622A (en) Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance
MY111630A (en) Amino acid derivatives.

Legal Events

Date Code Title Description
SPCF Filing an spc

Free format text: PRODUCT NAME: (S)-N-((ALFAS)-ALFA-((1R)-2-((3S,4AS,8AS)-3-(TRET-BUTILKARBAMOIL)OKTAHIDRO-2(1H)-IZOCHINOLIL)-1-HIDROKSIETIL)-2-CHINALDAMIDO SUKCINAMIDAS, MEZILATAS (SAQUINAVIR); REGISTRATION NO/DATE: EU/1/96/026/001 19961004

Spc suppl protection certif: PA2004003

Filing date: 20040730

Expiry date: 20130816

SPCR Rejection of an spc

Free format text: PRODUCT NAME: (S)-N-((ALFAS)-ALFA-((1R)-2-((3S,4AS,8AS)-3-(TRET-BUTILKARBAMOIL)OKTAHIDRO-2(1H)-IZOCHINOLIL)-1-HIDROKSIETIL)-2-CHINALDAMIDO SUKCINAMIDAS, MEZILATAS (SAQUINAVIR); REGISTRATION NO/DATE: EU/1/96/026/001 19961004

Spc suppl protection certif: PA2004003

Filing date: 20040730

Expiry date: 20130816

Effective date: 20050927

MK9A Expiry of a patent

Effective date: 20130816